Investigating the effect of increasing the amount of prescribed progesterone on the pregnancy success rate
Phase 3
- Conditions
- Female infertilityFemale infertility.
- Registration Number
- IRCT20150105020558N6
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 218
Inclusion Criteria
Women with a three-layered endometrial pattern with sufficient thickness (7 mm) after receiving estrogen
Progesterone level less than 9.2 ng/ml on the day of transfer
With at least two three-day frozen embryos of good quality (AA, AB, BB)
Exclusion Criteria
The presence of underlying diseases such as malignancy, advanced heart failure, cirrhosis, progressive chronic neurological diseases, and uterine disorders such as fibroids, polyps, or hydrosalpinx.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ive birth. Timepoint: Once, after pregnancy termination. Method of measurement: The number of deliveries that resulted in a live-born neonate.
- Secondary Outcome Measures
Name Time Method